Showing results (41-50 of 66) with videos related to
Sort By:
Pageof 7
Oncotarget|November 16, 2017
Anti-pancreatic cancer activity of ONC212 involves the unfolded protein response (UPR) and is reduced by IGF1-R and GRP78/BIPAvital Lev, Amriti R Lulla, Jessica Wagner, et al.International Journal of Molecular Sciences|July 15, 2026
Off-Target-Based Tumor Fraction Estimation from Targeted Sequencing Shows Concordance with Orthogonal Methods Across Advanced Solid TumorsSamantha O Hasenleithner, Shilpa Rao, Jian Q Yu, et al.Annals of Surgical Oncology|August 21, 2010
Defining venous involvement in borderline resectable pancreatic cancerYun Shin Chun, Barton N Milestone, James C Watson, et al.Cell Reports|September 8, 2015
Endogenous Sterol Metabolites Regulate Growth of EGFR/KRAS-Dependent Tumors via LXRLinara Gabitova, Diana Restifo, Andrey Gorin, et al.Molecular Cancer Therapeutics|August 11, 2016
EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck CancerTim N Beck, Rachel Georgopoulos, Elena I Shagisultanova, et al.Journal of Gastrointestinal Cancer|February 15, 2025
Racial/Ethnic Differences and Effects of Clinical/Socioeconomic Factors on Time from Diagnosis to Treatment in Pancreatic CancerAnush Sridharan, Efrat Dotan, Marianna Dorta, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2020
Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic CancerEfrat Dotan, Dana B Cardin, Heinz-Josef Lenz, et al.Molecular Cancer Therapeutics|August 8, 2023
Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic Cancers with DNA Damage Repair DeficienciesDiana Restifo, Joseph R McDermott, Dusica Cvetkovic, et al.NPJ Precision Oncology|June 15, 2026
Optimization of first-line treatment selection in advanced pancreatic adenocarcinoma using artificial intelligenceSebastian Cole, Paul Campitelli, Brian Grieb, et al.Science Signaling|September 23, 2010
Synthetic lethal screen of an EGFR-centered network to improve targeted therapiesIgor Astsaturov, Vladimir Ratushny, Anna Sukhanova, et al.Pageof 7